Toll-like receptor (TLR)-mediated innate immune responses are important in early host defense. Using a candidate gene approach, we previously identified genetic variation within TLR1 that is associated with hyper-responsiveness to a TLR1/2 agonist in vitro and with death and organ dysfunction in patients with sepsis. Here we report a genome-wide association study (GWAS) designed to identify genetic loci controlling whole blood cytokine responses to the TLR1/2 lipopeptide agonist, Pam 3 CSK 4 (N-palmitoyl-S-dipalmitoylglyceryl Cys-Ser-(Lys) 4) ex vivo. We identified a very strong association (P<1 × 10-27) between genetic variation within the TLR10/1/6 locus on chromosome 4, and Pam 3 CSK 4-induced cytokine responses. This was the predominant association explaining over 35% of the population variance for this phenotype. Notably, strong associations were observed within TLR10, suggesting that genetic variation in TLR10 may influence bacterial lipoprotein-induced responses. These findings establish the TLR10/1/6 locus as the dominant common genetic factor controlling interindividual variability in Pam 3 CSK 4-induced whole blood responses in the healthy population. © 2013 Macmillan Publishers Limited All rights reserved.
CITATION STYLE
Mikacenic, C., Reiner, A. P., Holden, T. D., Nickerson, D. A., & Wurfel, M. M. (2013). Variation in the TLR10/TLR1/TLR6 locus is the major genetic determinant of interindividual difference in TLR1/2-mediated responses. Genes and Immunity, 14(1), 52–57. https://doi.org/10.1038/gene.2012.53
Mendeley helps you to discover research relevant for your work.